Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1971 1
1981 1
2003 1
2004 2
2007 2
2008 4
2009 6
2010 7
2011 8
2012 4
2013 2
2014 1
2015 1
2016 1
2017 6
2018 2
2019 2
2020 4
2021 6
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. Among authors: schettino c. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. Among authors: schettino c. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Erlotinib in cancer treatment.
Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Bareschino MA, et al. Among authors: schettino c. Ann Oncol. 2007 Jun;18 Suppl 6:vi35-41. doi: 10.1093/annonc/mdm222. Ann Oncol. 2007. PMID: 17591829 Free article. Review.
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.
De Luca A, Esposito Abate R, Rachiglio AM, Maiello MR, Esposito C, Schettino C, Izzo F, Nasti G, Normanno N. De Luca A, et al. Among authors: schettino c. Int J Mol Sci. 2020 Sep 18;21(18):6856. doi: 10.3390/ijms21186856. Int J Mol Sci. 2020. PMID: 32962091 Free PMC article. Review.
Pemetrexed in advanced non-small cell lung cancer.
Gridelli C, Maione P, Rossi A, Bareschino MA, Schettino C, Sacco PC, Zeppa R. Gridelli C, et al. Among authors: schettino c. Expert Opin Drug Saf. 2011 Mar;10(2):311-7. doi: 10.1517/14740338.2011.553281. Epub 2011 Jan 25. Expert Opin Drug Saf. 2011. PMID: 21261558 Review.
Irreversible EGFR inhibitors in the treatment of advanced NSCLC.
Maione P, Rossi A, Bareschino M, Sacco PC, Schettino C, Casaluce F, Sgambato A, Gridelli C. Maione P, et al. Among authors: schettino c. Curr Pharm Des. 2014;20(24):3894-900. doi: 10.2174/13816128113196660764. Curr Pharm Des. 2014. PMID: 24138713 Review.
New molecular targets in the treatment of NSCLC.
Schettino C, Bareschino MA, Sacco PC, Maione P, Rossi A, Casaluce F, Sgambato A, Gridelli C. Schettino C, et al. Curr Pharm Des. 2013;19(30):5333-43. doi: 10.2174/13816128113199990343. Curr Pharm Des. 2013. PMID: 23394083 Review.
Targeting angiogenesis for treatment of NSCLC brain metastases.
Schettino C, Bareschino MA, Rossi A, Maione P, Sacco PC, Colantuoni G, Rossi E, Gridelli C. Schettino C, et al. Curr Cancer Drug Targets. 2012 Mar;12(3):289-99. doi: 10.2174/156800912799277476. Curr Cancer Drug Targets. 2012. PMID: 22229249 Review.
62 results